Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Severe enzyme deficiency is typically corrected with prescription enzyme replacement therapy dosed with every meal and snack, alongside treatment of the underlying cause such as chronic pancreatitis, cystic fibrosis, celiac disease, or an inherited metabolic condition. Doctor-approved steps also include repleting fat-soluble vitamins, adjusting fat and fiber intake, spacing acid-reducing medication correctly, and tracking weight, stool changes, and bloodwork to confirm the dose is working. Dosing, timing, and diet changes differ by diagnosis and severity, and there are several important factors to consider before starting or changing anything, so see below for the complete answer. Red flags like rapid weight loss, greasy or floating stools, severe abdominal pain, or signs of dehydration warrant prompt medical care rather than self-treatment.
Because symptoms of enzyme deficiency overlap with many other digestive and metabolic conditions, the fastest way to know which path fits you is to run a free, instant, online symptom check and bring those results to your clinician to guide testing and next steps.
Last reviewed for medical accuracy: 08/18/2026
Alkaline phosphatase (ALP) is an enzyme found throughout the body—especially in your liver, bones and intestines. When ALP levels drop too low, it can signal serious health issues such as hypophosphatasia (a rare genetic disorder), malnutrition or mineral imbalances. Left unaddressed, low alkaline phosphatase can lead to bone pain, fractures, dental problems and muscle weakness. Fortunately, there are clear, doctor-approved steps you can take.
Alkaline phosphatase helps regulate bone mineralization and supports liver function. Normal ALP ranges vary by age and sex but generally sit between 44–147 IU/L in adults. If your blood test shows values below this range, it’s called hypophosphatasemia.
Common causes include:
Recognizing the underlying cause is crucial. Your doctor may order additional tests—such as genetic screening, vitamin panels or imaging studies—to pinpoint why your ALP is low.
Before jumping into treatment, make sure you and your healthcare provider have a clear picture:
If you’re unsure about your symptoms or lab results, try a free, online symptom check, using the doctor approved Ubie Symptom Checker.
For severe hypophosphatasia—especially in infants, children with bone deformities or adults with recurrent fractures—the only FDA-approved treatment is asfotase alfa (Strensiq), an enzyme replacement. Key points:
Asfotase alfa helps rebuild bone mineral density, improves mobility and can reduce pain. However, this therapy is expensive and requires lifelong follow-up.
Mild to moderate cases of low alkaline phosphatase can often improve with targeted nutrition:
• Zinc:
• Magnesium:
• Vitamin B6 (Pyridoxine):
• Vitamin D and Calcium:
Tips for maximizing absorption:
Always discuss supplement use with your doctor to avoid interactions or over-supplementation.
Sometimes, low ALP is a symptom of a broader health issue. Treating that condition can restore enzyme levels:
Regular follow-up labs every 3–6 months help track progress.
Bone and muscle health benefit from a holistic approach:
• Weight-bearing exercise:
• Physical therapy:
• Fall prevention:
• Dental care:
Once treatment starts:
Adjust doses based on lab trends and symptoms. Consistent communication with your healthcare team is vital.
Low alkaline phosphatase itself isn’t always an emergency, but complications can be serious:
If you experience any of these, call your doctor or go to the nearest emergency department. For non-urgent concerns, you can also try a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Treating severe enzyme deficiency—particularly low alkaline phosphatase—requires a multi-pronged, doctor-supervised approach. Whether you need enzyme replacement therapy, targeted nutrition or management of an underlying disease, early diagnosis and consistent follow-up improve outcomes.
Always speak to your doctor about symptoms that could be life-threatening or serious. With the right treatment plan and support, you can restore enzyme levels, strengthen your bones and get back to daily life.
(References)
* Vockley J, Andersson HC, Antshel KM, Braverman NE, Burton BK, Frazier DM, Mitchell J, Smith WE, Thompson BH, Berry SA, American College of Medical Genetics and Genomics Therapeutics Committee. Phenylalanine hydroxylase deficiency: diagnosis and management guideline. Genet Med. 2014 Feb;16(2):188-200. doi: 10.1038/gim.2013.157. Epub 2013 Oct 10. PMID: 24385074.
* Suarez-Guerrero JL, Gómez Higuera PJ, Arias Flórez JS, Contreras-García GA. [Mucopolysaccharidosis: clinical features, diagnosis and management]. Rev Chil Pediatr. 2016 Jul-Aug;87(4):295-304. doi: 10.1016/j.rchipe.2015.10.004. Epub 2015 Nov 21. PMID: 26613630.
* Vargas-Santos AB, Neogi T. Management of Gout and Hyperuricemia in CKD. Am J Kidney Dis. 2017 Sep;70(3):422-439. doi: 10.1053/j.ajkd.2017.01.055. Epub 2017 Apr 26. PMID: 28456346; PMCID: PMC5572666.
* El-Maouche D, Arlt W, Merke DP. Congenital adrenal hyperplasia. Lancet. 2017 Nov 11;390(10108):2194-2210. doi: 10.1016/S0140-6736(17)31431-9. Epub 2017 May 30. PMID: 28576284.
* Ortiz A, Germain DP, Desnick RJ, Politei J, Mauer M, Burlina A, Eng C, Hopkin RJ, Laney D, Linhart A, Waldek S, Wallace E, Weidemann F, Wilcox WR. Fabry disease revisited: Management and treatment recommendations for adult patients. Mol Genet Metab. 2018 Apr;123(4):416-427. doi: 10.1016/j.ymgme.2018.02.014. Epub 2018 Feb 28. PMID: 29530533.
* Gujral J, Sethuram S. An update on the diagnosis and treatment of adrenoleukodystrophy. Curr Opin Endocrinol Diabetes Obes. 2023 Feb 1;30(1):44-51. doi: 10.1097/MED.0000000000000782. Epub 2022 Nov 14. PMID: 36373727.
* Auer MK, Nordenström A, Lajic S, Reisch N. Congenital adrenal hyperplasia. Lancet. 2023 Jan 21;401(10372):227-244. doi: 10.1016/S0140-6736(22)01330-7. Epub 2022 Dec 8. PMID: 36502822.
* Gümüş E, Özen H. Glycogen storage diseases: An update. World J Gastroenterol. 2023 Jul 7;29(25):3932-3963. doi: 10.3748/wjg.v29.i25.3932. PMID: 37476587; PMCID: PMC10354582.
* Talebi S, Eshraghi P. Nutrition in phenylketonuria. Clin Nutr ESPEN. 2024 Dec;64:307-313. doi: 10.1016/j.clnesp.2024.09.032. Epub 2024 Oct 19. PMID: 39427751.
* Seefried L, Genest F, Hofmann C, Brandi ML, Rush E. Diagnosis and Treatment of Hypophosphatasia. Calcif Tissue Int. 2025 Mar 6;116(1):46. doi: 10.1007/s00223-025-01356-y. Epub 2025 Mar 6. PMID: 40047955; PMCID: PMC11885340.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.